Commercial Bancgroup, Inc. Common Stock
NASDAQ:CBKBanks
-$0.17 today
- Market cap
- $442.57M
- Beta
- 0.68
- P/E (TTM)
- 11.2
- EPS (TTM)
- $2.76
- Dividend yield
- 0.65%
Volume 0.03M
Average 0.06M
CBK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Commercial Bancgroup, Inc. Common StockNASDAQ: CBK
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
Research & Development vs competitors
How CBK compares with its peers on the latest reported figures
- CBK's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CBK, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
HTBHomeTrust Bancshares, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CBK) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CBK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 112.2M | 133.33M | 131.53M |
| Cost of Revenue | 33.81M | 47.46M | 41.32M |
| Gross Profit | 78.39M | 85.87M | 90.21M |
| Gross Margin | 69.9% | 64.4% | 68.6% |
| Research & Development | 0 | 0 | 0 |
| Selling, General & Admin | 21.78M | 26M | 26.03M |
| Operating Expenses | 38.7M | 45.3M | 42.48M |
| Depreciation & Amortization | 3.54M | 4.59M | 2.14M |
| EBITDA | 43.23M | 45.17M | 49.56M |
| EBITDA Margin | 38.5% | 33.9% | 37.7% |
| Operating Income | 39.69M | 40.57M | 47.42M |
| Operating Margin | 35.4% | 30.4% | 36.0% |
| Interest Income | 102.64M | 123.21M | 121.6M |
| Interest Expense | 30.54M | 45.63M | 41.17M |
| Other Income / Expenses | 0 | 0 | 0 |
| Income Before Tax | 39.69M | 40.57M | 47.42M |
| Pre-Tax Margin | 35.4% | 30.4% | 36.0% |
| Income Tax Expense | 8.48M | 8.89M | 10.22M |
| Net Income | 30.69M | 31.41M | 37.2M |
| Net Margin | 27.4% | 23.6% | 28.3% |
| EPS (Basic) | 2.52 | 2.58 | 2.93 |
| EPS (Diluted) | 2.51 | 2.54 | 2.92 |
| Weighted Avg Shares | 12.18M | 12.17M | 13.84M |
| Weighted Avg Shares (Diluted) | 12.23M | 12.37M | 13.84M |
Commercial Bancgroup, Inc. Common Stock
NASDAQ:CBK
Intrinsic Alpha fair value
Locked
Current Price
$32.28
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.